{
    "hands_on_practices": [
        {
            "introduction": "A common challenge in clinical practice is to quantify medication adherence using readily available information, such as pharmacy refill records. This exercise introduces a foundational metric, the Medication Possession Ratio ($MPR$), which estimates adherence by comparing the total days' supply of medication a patient has obtained against the total number of days in an observation period. Mastering this calculation is a fundamental skill for interpreting patient behavior from administrative health data and identifying individuals who may need additional support .",
            "id": "5107433",
            "problem": "A pediatric clinic is monitoring adherence to stimulant pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD). A child has an observation window of $120$ days during which pharmacy claims show $3$ fills, each dispensed with a $30$-day supply. Assume the observation window is fixed at $120$ days regardless of refill timing, there is no inpatient period or medication hold, and there is no adjustment for pill-splitting or early refill stockpiling. Using the standard definition of medication possession ratio (MPR) employed in pediatric pharmacotherapy quality measurement, compute the adherence as the medication possession ratio over the $120$-day period. Express your answer as a decimal to three significant figures. In your reasoning, briefly state the clinical implication for follow-up if a clinic applies an adherence threshold of $0.80$ for triggering earlier reassessment, but report only the computed MPR as your final numeric answer.",
            "solution": "The problem will first be validated for scientific and logical consistency.\n\n### Step 1: Extract Givens\n- Observation window: $120$ days\n- Number of pharmacy claims (fills): $3$\n- Days' supply per fill: $30$ days\n- Assumptions:\n    - The observation window is fixed at $120$ days.\n    - There is no inpatient period or medication hold.\n    - There is no adjustment for pill-splitting or early refill stockpiling.\n- Task: Compute the medication possession ratio (MPR) and express it as a decimal to three significant figures.\n- Additional task: State the clinical implication if an adherence threshold of $0.80$ is applied.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the required criteria.\n- **Scientifically Grounded**: The problem statement is scientifically sound. Medication Possession Ratio (MPR) is a standard and widely used metric in health services research and clinical quality measurement to estimate medication adherence. The scenario described is a common application in pediatric pharmacotherapy for chronic conditions like ADHD.\n- **Well-Posed**: The problem is well-posed. It provides all necessary data (total days in the observation period, number of fills, and days' supply per fill) to calculate the MPR according to its standard definition. The assumptions provided (e.g., no adjustment for stockpiling) remove ambiguity.\n- **Objective**: The problem is stated in clear, objective language, free of subjective or opinion-based claims.\n\nThe problem does not violate any of the specified flaw conditions. It is scientifically valid, formally coherent, and presents a realistic scenario for calculation. Therefore, the problem is deemed valid and a solution will be provided.\n\n### Solution\nThe Medication Possession Ratio (MPR) is a measure of adherence to a prescribed medication regimen. It is calculated as the total number of days' supply of a medication obtained by a patient during a specific period, divided by the total number of days in that period.\n\nThe formula for MPR is:\n$$\n\\text{MPR} = \\frac{\\text{Sum of days' supply for all fills}}{\\text{Number of days in the observation period}}\n$$\nFrom the provided data, we have:\n- Number of fills = $3$\n- Days' supply per fill = $30$ days\n- Observation period = $120$ days\n\nFirst, we calculate the total days' supply obtained by the patient. This is the product of the number of fills and the days' supply per fill.\n$$\n\\text{Total days' supply} = (\\text{Number of fills}) \\times (\\text{Days' supply per fill})\n$$\n$$\n\\text{Total days' supply} = 3 \\times 30 \\text{ days} = 90 \\text{ days}\n$$\nNext, we substitute this value and the length of the observation period into the MPR formula.\n$$\n\\text{MPR} = \\frac{90 \\text{ days}}{120 \\text{ days}}\n$$\nThe ratio simplifies to:\n$$\n\\text{MPR} = \\frac{9}{12} = \\frac{3}{4} = 0.75\n$$\nThe problem requires the answer to be expressed as a decimal to three significant figures. Therefore, $0.75$ is written as $0.750$.\n\nRegarding the clinical implication, the problem specifies a clinical adherence threshold of $0.80$ for triggering earlier reassessment. The calculated MPR for this patient is $0.750$. Since $0.750 < 0.80$, the patient's adherence level falls below the clinic's threshold for acceptable adherence. This would signal to the clinical team that the patient is potentially non-adherent and should be prioritized for follow-up. This reassessment would typically involve investigating the reasons for low adherence, which could include medication side effects, perceived lack of efficacy, family or logistical barriers, or a need to adjust the treatment plan.",
            "answer": "$$\\boxed{0.750}$$"
        },
        {
            "introduction": "While basic metrics provide a useful starting point, real-world data often contain complexities like early refills that lead to medication stockpiling. This practice moves beyond simple ratios to the Proportion of Days Covered ($PDC$), a more refined metric that handles oversupply by capping daily coverage at $100\\%$. By asking you to compute $PDC$ under two different but equally plausible rules for handling overlapping prescriptions, this exercise demonstrates how crucial methodological assumptions are in shaping the results of adherence research .",
            "id": "4724303",
            "problem": "A patient is prescribed a once-daily medication. Pharmacy claims provide refill records as date-of-fill and days’ supply. Proportion of Days Covered (PDC) is defined as the fraction of days in a fixed observation window on which the patient has at least one dose available. Proportion of Days Covered (PDC) counts coverage at most once per day and is bounded above by $1$ when computed as a fraction of days covered. Adherence measurement in medical psychology commonly uses refill-based estimators, which require explicit handling of overlapping fills (over-supply) and window truncation.\n\nConsider the following observation window and refill history. The observation window length is $L = 180$ days, indexed by integer days $t \\in \\{0,1,2,\\dots,179\\}$, where day $0$ is the index date. The refill claims are:\n- Day $0$: $30$ days’ supply.\n- Day $25$: $30$ days’ supply.\n- Day $60$: $90$ days’ supply.\n- Day $160$: $30$ days’ supply.\n\nAssume a once-daily regimen, so one unit of supply covers one day. Using only core definitions and well-tested conventions from refill-based adherence measurement, do the following:\n1. Derive how refill data map to day-level coverage indicators $c(t) \\in \\{0,1\\}$ and the resulting $PDC = \\frac{1}{L}\\sum_{t=0}^{L-1} c(t)$, starting from first principles. Your derivation must explicitly handle overlapping fills and the observation window boundary.\n2. Compute $PDC$ under the following two truncation rules for over-supply:\n   - Rule $\\mathcal{C}$ (carryover within the window, standard PDC): If a refill occurs before the previous supply is exhausted, carry forward the unused supply so that the next coverage interval begins on the first uncovered day after the previous interval ends. No day may be counted more than once, and any supply that extends beyond day $179$ is discarded.\n   - Rule $\\mathcal{T}$ (truncate at each refill): If a refill occurs before the previous supply is exhausted, discard any remaining supply from the prior fill on the refill date; the new coverage begins on the refill date. No day may be counted more than once, and any supply that extends beyond day $179$ is discarded.\n3. Let $\\Delta$ be the absolute difference between the two $PDC$ values, $\\Delta = |PDC_{\\mathcal{C}} - PDC_{\\mathcal{T}}|$. Express your final answer for $\\Delta$ as a decimal fraction. Round your answer to four significant figures.",
            "solution": "The user wants me to solve a problem based on a given role and a set of instructions. I must first validate the problem statement.\n\n### Step 1: Extract Givens\n-   **Medication Regimen**: Once-daily.\n-   **Adherence Metric**: Proportion of Days Covered (PDC), defined as the fraction of days in a fixed observation window on which the patient has at least one dose available.\n-   **PDC Formula**: $PDC = \\frac{1}{L}\\sum_{t=0}^{L-1} c(t)$, where $c(t) \\in \\{0,1\\}$ is the coverage indicator for day $t$.\n-   **Observation Window**: Length $L = 180$ days, indexed by $t \\in \\{0, 1, 2, \\dots, 179\\}$.\n-   **Refill Claims Data**:\n    -   Fill 1: Day $d_1 = 0$, supply $s_1 = 30$ days.\n    -   Fill 2: Day $d_2 = 25$, supply $s_2 = 30$ days.\n    -   Fill 3: Day $d_3 = 60$, supply $s_3 = 90$ days.\n    -   Fill 4: Day $d_4 = 160$, supply $s_4 = 30$ days.\n-   **Rule $\\mathcal{C}$ (carryover)**: If a refill occurs before the previous supply is exhausted, the unused supply is carried forward so the next coverage interval begins on the first uncovered day after the previous interval ends. Supply extending beyond day $179$ is discarded.\n-   **Rule $\\mathcal{T}$ (truncate)**: If a refill occurs before the previous supply is exhausted, any remaining supply from the prior fill is discarded on the refill date, and the new coverage begins on the refill date. Supply extending beyond day $179$ is discarded.\n-   **Target Calculation**: $\\Delta = |PDC_{\\mathcal{C}} - PDC_{\\mathcal{T}}|$, rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is subjected to validation against the specified criteria.\n-   **Scientifically Grounded**: The problem is grounded in the established field of pharmacoepidemiology and medical psychology. The PDC is a standard, widely used metric for medication adherence. The handling of oversupply through carryover (Rule $\\mathcal{C}$, the standard PDC method) and truncation (Rule $\\mathcal{T}$, sometimes used as a sensitivity analysis) are well-defined, common conventions in the literature.\n-   **Well-Posed**: The problem is well-posed. The observation window, refill history, and the rules for calculating coverage are all explicitly and unambiguously defined. This ensures that a unique, stable, and meaningful solution for $PDC_{\\mathcal{C}}$, $PDC_{\\mathcal{T}}$, and $\\Delta$ exists.\n-   **Objective**: The problem is stated in objective, formal language. It is free of subjective claims or biases.\n-   **Completeness and Consistency**: The problem is self-contained. All data required for the calculation are provided, and there are no internal contradictions.\n-   **Realism**: The scenario is a simplified but realistic representation of data encountered in health claims databases.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is scientifically sound, well-posed, objective, and contains all necessary information for a unique solution. The solution process will now proceed.\n\n### Derivation and Calculation\n\nThe core of the problem is to determine the set of covered days within the observation window $[0, L-1]$, where $L=180$. The days are integers $t \\in \\{0, 1, \\dots, 179\\}$. For each day $t$, we determine the coverage indicator $c(t)$, which is $1$ if the patient has medication available and $0$ otherwise. The Proportion of Days Covered (PDC) is the total number of covered days, $\\sum c(t)$, divided by the length of the observation window, $L$.\n\nThe refill history is given by four events $(d_i, s_i)$: $(0, 30)$, $(25, 30)$, $(60, 90)$, and $(160, 30)$. We will analyze the coverage under each rule. A coverage interval is denoted as $[b, e)$, representing days $t$ such that $b \\le t < e$.\n\n**1. Calculation under Rule $\\mathcal{C}$ (carryover)**\n\nThis rule dictates that supply from overlapping fills is \"stacked\". We trace the coverage intervals chronologically.\n\n-   **Fill 1**: A supply of $s_1 = 30$ days is obtained on day $d_1 = 0$. This provides coverage for the interval $[0, 0+30) = [0, 30)$. The patient is theoretically covered until day $30$.\n\n-   **Fill 2**: A supply of $s_2 = 30$ days is obtained on day $d_2 = 25$. Since $d_2 = 25$ is before the previous supply runs out (day $30$), this is an oversupply. According to Rule $\\mathcal{C}$, this new supply is added to the stockpile. The total supply accumulated from day $0$ is now $s_1 + s_2 = 30 + 30 = 60$ days. This total supply provides a continuous coverage block starting from day $0$. The coverage interval is now $[0, 60)$. The patient is covered until day $60$.\n\n-   **Fill 3**: A supply of $s_3 = 90$ days is obtained on day $d_3 = 60$. The previous coverage ended precisely as the new fill occurs. There is no overlap and no gap. The new supply extends the coverage. The total continuous block of coverage now starts at day $0$ and lasts for $60 + 90 = 150$ days. The coverage interval is $[0, 150)$. The patient is covered until day $150$.\n\n-   **Fill 4**: A supply of $s_4 = 30$ days is obtained on day $d_4 = 160$. The previous supply ran out on day $150$. This creates a coverage gap from day $150$ to day $159$. The new coverage begins on the fill date, $d_4 = 160$. It would provide coverage for the interval $[160, 160+30) = [160, 190)$.\n\n-   **Final Coverage Set for $\\mathcal{C}$**: The union of all coverage intervals is $[0, 150) \\cup [160, 190)$. We must consider the observation window, which ends on day $179$ (i.e., the interval is $[0, 180)$). The effective coverage intervals are $[0, 150)$ and $[160, 180)$. These intervals are disjoint.\n-   The total number of covered days, $N_{\\mathcal{C}}$, is the sum of the lengths of these intervals:\n$$N_{\\mathcal{C}} = (150 - 0) + (180 - 160) = 150 + 20 = 170$$\n-   The PDC under Rule $\\mathcal{C}$ is:\n$$PDC_{\\mathcal{C}} = \\frac{N_{\\mathcal{C}}}{L} = \\frac{170}{180}$$\n\n**2. Calculation under Rule $\\mathcal{T}$ (truncate)**\n\nThis rule dictates that any remaining supply is discarded upon a new refill.\n\n-   **Fill 1**: A supply of $s_1 = 30$ days is obtained on day $d_1 = 0$. Initially, this creates a coverage interval of $[0, 30)$.\n\n-   **Fill 2**: A supply of $s_2 = 30$ days is obtained on day $d_2 = 25$. Since $d_2 = 25$ falls within the existing coverage interval $[0, 30)$, Rule $\\mathcal{T}$ applies. The supply from Fill 1 is truncated on day $25$. Its effective coverage interval becomes $[0, 25)$. The new supply from Fill 2 starts on the refill date, creating the interval $[25, 25+30) = [25, 55)$. The union of these two intervals gives continuous coverage over $[0, 55)$.\n\n-   **Fill 3**: A supply of $s_3 = 90$ days is obtained on day $d_3 = 60$. The previous coverage ended on day $55$. Since $d_3 = 60$ is after day $55$, there is no overlap. The truncation rule does not apply. This fill creates a new, separate coverage interval of $[60, 60+90) = [60, 150)$.\n\n-   **Fill 4**: A supply of $s_4 = 30$ days is obtained on day $d_4 = 160$. The previous coverage ended on day $150$. Since $d_4 = 160$ is after day $150$, there is no overlap. The truncation rule does not apply. This fill creates a new coverage interval of $[160, 160+30) = [160, 190)$.\n\n-   **Final Coverage Set for $\\mathcal{T}$**: The union of all coverage intervals is $[0, 55) \\cup [60, 150) \\cup [160, 190)$. Intersecting this with the observation window $[0, 180)$ yields the effective disjoint intervals: $[0, 55)$, $[60, 150)$, and $[160, 180)$.\n-   The total number of covered days, $N_{\\mathcal{T}}$, is the sum of the lengths of these intervals:\n$$N_{\\mathcal{T}} = (55 - 0) + (150 - 60) + (180 - 160) = 55 + 90 + 20 = 165$$\n-   The PDC under Rule $\\mathcal{T}$ is:\n$$PDC_{\\mathcal{T}} = \\frac{N_{\\mathcal{T}}}{L} = \\frac{165}{180}$$\n\n**3. Calculation of the Absolute Difference $\\Delta$**\n\nThe final step is to compute the absolute difference between the two PDC values.\n\n$$ \\Delta = |PDC_{\\mathcal{C}} - PDC_{\\mathcal{T}}| = \\left| \\frac{170}{180} - \\frac{165}{180} \\right| = \\left| \\frac{170 - 165}{180} \\right| = \\frac{5}{180} $$\n\nTo express this as a decimal fraction, we perform the division:\n$$ \\frac{5}{180} = \\frac{1}{36} = 0.027777... $$\n\nThe problem requires rounding the answer to four significant figures. The first significant figure is the $2$. The first four significant figures are $2$, $7$, $7$, $7$. The digit following this sequence is $7$, which is $\\ge 5$, so we round up the last digit.\n$$ \\Delta \\approx 0.02778 $$\nThis value represents the difference in the estimated proportion of time the patient was adherent, based solely on the choice of convention for handling a $5$-day oversupply that was carried over in one model and discarded in the other.",
            "answer": "$$\\boxed{0.02778}$$"
        },
        {
            "introduction": "Adherence data can do more than just provide a summary score; it can reveal dynamic patterns in patient behavior. This exercise explores \"white-coat adherence,\" a psychological phenomenon where patients increase their medication-taking just before a clinical visit, and challenges you to use a formal statistical method to detect it . You will apply the generalized likelihood-ratio test to compare adherence rates in a pre-visit window to a baseline period, providing a hands-on demonstration of how to test a behavioral hypothesis with real-world data.",
            "id": "4724248",
            "problem": "A patient is prescribed a once-daily antihypertensive medication. Electronic Medication Event Monitoring System (MEMS) logs record time-stamped cap openings. In medical psychology, \"white-coat adherence\" refers to increased medication-taking behavior immediately before clinical visits, often driven by anticipatory evaluation concerns and impression management motives. To detect such pre-visit spikes analytically, consider modeling daily adherence as independent Bernoulli trials: each day is a \"success\" if at least one opening occurs and a \"failure\" otherwise. Assume two contiguous windows before a scheduled visit at day $0$: a baseline window of $T$ days and a pre-visit window of $w$ days.\n\nStarting from the Bernoulli model and the binomial likelihood, derive the generalized likelihood-ratio statistic that compares the null hypothesis $H_0$ (a single adherence probability across both windows) to the alternative $H_1$ (distinct adherence probabilities, allowing an increase in the pre-visit window). Then, for the following scientifically realistic MEMS summary data, compute the value of this statistic:\n\n- Baseline window length $T = 28$ days with $X_b = 18$ successes,\n- Pre-visit window length $w = 7$ days with $X_s = 7$ successes.\n\nRound your answer to four significant figures. Express the final value as a dimensionless quantity.",
            "solution": "The problem requires the derivation and computation of the generalized likelihood-ratio statistic for comparing two hypotheses about medication adherence probabilities. The process begins with a formal validation of the problem statement.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n-   **Model**: Daily adherence is a sequence of independent Bernoulli trials. A \"success\" is at least one medication cap opening; a \"failure\" is none.\n-   **Data Structure**: Two contiguous, independent windows of observations.\n    -   A baseline window of length $T$ days with $X_b$ successes.\n    -   A pre-visit window of length $w$ days with $X_s$ successes.\n-   **Hypotheses**:\n    -   Null Hypothesis ($H_0$): There is a single, constant adherence probability, $p_0$, across both windows.\n    -   Alternative Hypothesis ($H_1$): There are distinct adherence probabilities, $p_b$ for the baseline window and $p_s$ for the pre-visit window.\n-   **Specific Data values**:\n    -   $T = 28$\n    -   $X_b = 18$\n    -   $w = 7$\n    -   $X_s = 7$\n-   **Task**:\n    1.  Derive the generalized likelihood-ratio statistic.\n    2.  Compute its value for the given data.\n    3.  Round the final answer to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientific Grounding**: The problem is well-grounded in statistical theory and its application to behavioral medicine. Modeling dichotomous outcomes (adherence/non-adherence) with Bernoulli trials is a standard and appropriate statistical practice. The use of the generalized likelihood-ratio test is a fundamental method for hypothesis testing. The concept of \"white-coat adherence\" is a documented phenomenon in medical psychology, making the context scientifically realistic.\n-   **Well-Posedness**: The problem is well-posed. The hypotheses are clearly formulated, all necessary data are provided, and the objective is to compute a specific, well-defined statistical quantity. There is a unique solution.\n-   **Objectivity**: The problem is stated in precise, objective language, free from subjectivity or bias.\n-   **Consistency and Completeness**: The provided data are internally consistent (e.g., $X_b \\le T$ and $X_s \\le w$) and sufficient for the task.\n\n**Step 3: Verdict and Action**\n-   The problem is valid as it is scientifically sound, well-posed, objective, and complete. I will proceed with the solution.\n\n### Derivation and Solution\n\nLet $p_b$ be the probability of adherence on any given day in the baseline window and $p_s$ be the probability of adherence on any given day in the pre-visit window. The number of successes in each window follows a binomial distribution, as the trials are independent.\n-   Baseline window: $X_b \\sim \\text{Binomial}(T, p_b)$\n-   Pre-visit window: $X_s \\sim \\text{Binomial}(w, p_s)$\n\nBecause the two windows are independent, the joint likelihood function for the parameters $(p_b, p_s)$ given the data $(X_b, X_s)$ is the product of the two binomial probability mass functions:\n$$L(p_b, p_s | X_b, X_s) = \\binom{T}{X_b} p_b^{X_b} (1-p_b)^{T-X_b} \\cdot \\binom{w}{X_s} p_s^{X_s} (1-p_s)^{w-X_s}$$\n\n**Alternative Hypothesis ($H_1$)**\nUnder the alternative hypothesis, $p_b$ and $p_s$ are permitted to be different. The parameter space is $\\Omega_1 = \\{ (p_b, p_s) | 0 \\le p_b \\le 1, 0 \\le p_s \\le 1 \\}$. We find the maximum likelihood estimates (MLEs) by maximizing $L(p_b, p_s)$ with respect to $p_b$ and $p_s$ separately. The MLEs are the sample proportions of success in each window:\n$$ \\hat{p}_b = \\frac{X_b}{T} $$\n$$ \\hat{p}_s = \\frac{X_s}{w} $$\nThe maximized likelihood under $H_1$, denoted $L_1$, is found by substituting these MLEs into the likelihood function:\n$$ L_1 = L(\\hat{p}_b, \\hat{p}_s | X_b, X_s) = \\binom{T}{X_b} \\left(\\frac{X_b}{T}\\right)^{X_b} \\left(1-\\frac{X_b}{T}\\right)^{T-X_b} \\cdot \\binom{w}{X_s} \\left(\\frac{X_s}{w}\\right)^{X_s} \\left(1-\\frac{X_s}{w}\\right)^{w-X_s} $$\n\n**Null Hypothesis ($H_0$)**\nUnder the null hypothesis, there is a single adherence probability, $p_0$, such that $p_b = p_s = p_0$. The parameter space is restricted to $\\Omega_0 = \\{ (p, p) | 0 \\le p \\le 1 \\}$. We can pool the data from both windows. The total number of trials is $N = T+w$ and the total number of successes is $X = X_b+X_s$. The MLE for the common probability $p_0$ is the overall proportion of successes:\n$$ \\hat{p}_0 = \\frac{X_b+X_s}{T+w} $$\nThe maximized likelihood under $H_0$, denoted $L_0$, is found by substituting $p_b = p_s = \\hat{p}_0$ into the original likelihood function:\n$$ L_0 = L(\\hat{p}_0, \\hat{p}_0 | X_b, X_s) = \\binom{T}{X_b} \\hat{p}_0^{X_b} (1-\\hat{p}_0)^{T-X_b} \\cdot \\binom{w}{X_s} \\hat{p}_0^{X_s} (1-\\hat{p}_0)^{w-X_s} $$\n$$ L_0 = \\binom{T}{X_b} \\binom{w}{X_s} \\hat{p}_0^{X_b+X_s} (1-\\hat{p}_0)^{(T+w)-(X_b+X_s)} $$\n\n**Generalized Likelihood-Ratio (GLR) Statistic**\nThe GLR statistic, $\\Lambda$, is the ratio of the maximized likelihood under $H_0$ to the maximized likelihood under $H_1$:\n$$ \\Lambda = \\frac{L_0}{L_1} = \\frac{\\sup_{\\theta \\in \\Omega_0} L(\\theta)}{\\sup_{\\theta \\in \\Omega_1} L(\\theta)} $$\nSubstituting the expressions for $L_0$ and $L_1$:\n$$ \\Lambda = \\frac{\\binom{T}{X_b} \\binom{w}{X_s} \\hat{p}_0^{X_b+X_s} (1-\\hat{p}_0)^{T+w-X_b-X_s}}{\\binom{T}{X_b} \\hat{p}_b^{X_b} (1-\\hat{p}_b)^{T-X_b} \\cdot \\binom{w}{X_s} \\hat{p}_s^{X_s} (1-\\hat{p}_s)^{w-X_s}} $$\nThe binomial coefficient terms $\\binom{T}{X_b}$ and $\\binom{w}{X_s}$ cancel, yielding the derived statistic:\n$$ \\Lambda = \\frac{\\left(\\frac{X_b+X_s}{T+w}\\right)^{X_b+X_s} \\left(1-\\frac{X_b+X_s}{T+w}\\right)^{T+w-X_b-X_s}}{\\left(\\frac{X_b}{T}\\right)^{X_b} \\left(1-\\frac{X_b}{T}\\right)^{T-X_b} \\left(\\frac{X_s}{w}\\right)^{X_s} \\left(1-\\frac{X_s}{w}\\right)^{w-X_s}} $$\nFor practical hypothesis testing, the GLR test statistic, often denoted $\\lambda$, is used. It is defined as $\\lambda = -2 \\ln \\Lambda$. By Wilks' theorem, for large samples, $\\lambda$ follows a chi-squared distribution under $H_0$ with degrees of freedom equal to the difference in the dimensionality of the parameter spaces of $H_1$ and $H_0$. Here, $df = 2-1=1$. We will compute the value of this test statistic $\\lambda$.\n$$ \\lambda = -2 \\ln \\Lambda = 2 (\\ln L_1 - \\ln L_0) $$\n\n**Calculation for the Given Data**\nThe specific data are: $T=28$, $X_b=18$, $w=7$, $X_s=7$.\n\nFirst, we compute the MLEs:\nUnder $H_1$:\n$$ \\hat{p}_b = \\frac{X_b}{T} = \\frac{18}{28} = \\frac{9}{14} $$\n$$ \\hat{p}_s = \\frac{X_s}{w} = \\frac{7}{7} = 1 $$\nUnder $H_0$:\n$$ \\hat{p}_0 = \\frac{X_b+X_s}{T+w} = \\frac{18+7}{28+7} = \\frac{25}{35} = \\frac{5}{7} $$\n\nNow, we compute the log-likelihoods (ignoring the constant binomial coefficients, as they cancel in the ratio).\nThe log-likelihood for the full model is $\\ell_1 = (X_b \\ln \\hat{p}_b + (T-X_b)\\ln(1-\\hat{p}_b)) + (X_s \\ln \\hat{p}_s + (w-X_s)\\ln(1-\\hat{p}_s))$.\nFor the case where $\\hat{p}_s=1$, the second term becomes $X_s \\ln(1) + (w-X_s)\\ln(0)$. Since $w-X_s = 7-7=0$, this term is $7\\ln(1) + 0\\ln(0)$. The limit $\\lim_{x\\to 0} x\\ln x = 0$, so we define $0\\ln0=0$. Thus, the second term evaluates to $0$.\n$$ \\ell_1 = 18 \\ln\\left(\\frac{18}{28}\\right) + (28-18) \\ln\\left(1-\\frac{18}{28}\\right) + 0 $$\n$$ \\ell_1 = 18 \\ln\\left(\\frac{9}{14}\\right) + 10 \\ln\\left(\\frac{10}{28}\\right) = 18 \\ln\\left(\\frac{9}{14}\\right) + 10 \\ln\\left(\\frac{5}{14}\\right) $$\n$$ \\ell_1 \\approx -18.24918 $$\n\nThe log-likelihood for the null model is $\\ell_0 = (X_b+X_s)\\ln \\hat{p}_0 + (T+w-X_b-X_s)\\ln(1-\\hat{p}_0)$.\n$$ \\ell_0 = 25 \\ln\\left(\\frac{25}{35}\\right) + (35-25) \\ln\\left(1-\\frac{25}{35}\\right) $$\n$$ \\ell_0 = 25 \\ln\\left(\\frac{5}{7}\\right) + 10 \\ln\\left(\\frac{10}{35}\\right) = 25 \\ln\\left(\\frac{5}{7}\\right) + 10 \\ln\\left(\\frac{2}{7}\\right) $$\n$$ \\ell_0 \\approx -20.93944 $$\n\nFinally, we compute the test statistic $\\lambda$:\n$$ \\lambda = -2 \\ln\\Lambda = 2(\\ell_1 - \\ell_0) $$\n$$ \\lambda \\approx 2(-18.24918 - (-20.93944)) = 2(-18.24918 + 20.93944) = 2(2.69026) $$\n$$ \\lambda \\approx 5.38052 $$\nRounding to four significant figures, the value is 5.381.\nThis value represents the generalized likelihood-ratio test statistic $\\lambda = -2 \\ln \\Lambda$.",
            "answer": "$$\\boxed{5.381}$$"
        }
    ]
}